Join ArmchairMedical [Click here for more information]
Live stream preview

Watch this video and more on armchairmedical.tv

Watch this video and more on armchairmedical.tv

Subscribe Learn more

Already subscribed? Sign in

The proportion of patients who reach the BMD surrogate threshold effect on romosozumab a post hoc analysis of the randomised FRAME and ARCH phase 3 trials Prof Jeffrey Hassall

ANZ Bone & Mineral Society 2022 • 9m 51s

Up Next in ANZ Bone & Mineral Society 2022

×